Landfar Bio-medicine Co., Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 194.48 million compared to CNY 156.54 million a year ago. Revenue was CNY 200.35 million compared to CNY 156.62 million a year ago.

Net loss was CNY 12.69 million compared to CNY 19.13 million a year ago. Basic loss per share from continuing operations was CNY 0.04 compared to CNY 0.06 a year ago. Diluted loss per share from continuing operations was CNY 0.04 compared to CNY 0.06 a year ago.